Welcome to LookChem.com Sign In|Join Free
  • or
N-(9-{5-(tert-butyl-diphenyl-silanyloxymethyl)-4-hydroxy-3-[2-(N-methyl-aminooxy)-ethoxy]-tetrahydro-furan-2-yl}-9H-purin-6-yl)-benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

433288-70-1

Post Buying Request

433288-70-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

433288-70-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 433288-70-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,3,2,8 and 8 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 433288-70:
(8*4)+(7*3)+(6*3)+(5*2)+(4*8)+(3*8)+(2*7)+(1*0)=151
151 % 10 = 1
So 433288-70-1 is a valid CAS Registry Number.

433288-70-1Relevant academic research and scientific papers

Synthesis of 2′O-[2-[(N,N-dimethylamino)oxy]ethyl] modified nucleosides and oligonucleotides

Prakash, Thazha P.,Kawasaki, Andrew M.,Fraser, Allister S.,Vasquez, Guillermo,Manoharan, Muthiah

, p. 357 - 369 (2007/10/03)

A versatile synthetic route has been developed for the synthesis of 2′-O-[2-[(N,N-dimethylamino)oxy]ethyl] (abbreviated as 2′-O-DMAOE) modified purine and pyrimidine nucleosides and their corresponding nucleoside phosphoramidites and solid supports. To synthesize 2′-O-n DMAOE purine nucleosides, the key intermediate B (Scheme 1) was obtained from the 2′-O-allyl purine nucleosides (13a and 15) via oxidative cleavage of the carbon-carbon bond to the corresponding aldehydes followed by reduction. To synthesize pyrimidine nucleosides, opening the 2,2′-anhydro-5-methyluridine 5 with the borate ester of ethylene glycol gave the key intermediate B. The 2′-O-(2hydroxyethyl) nucleosides were converted, in excellent yield, by a regioselective Mitsunobu reaction, to the corresponding 2′-O-[2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]ethyl] nucleosides (18, 19, and 20). These compounds were subsequently deprotected and converted into the 2′-O-[2[(methyleneamino)oxy]ethyl] derivatives (22, 23, and 24). Reduction and a second reductive amination with formaldehyde yielded the corresponding 2′-O-[2-[(N,N-dimethylamino)oxy]ethyl] nucleosides (25, 26, and 27). These nucleosides were converted to their 3′-O-phosphoramidites and controlled-pore glass solid supports in excellent overall yield. Using these monomers, modified oligonucleotides containing pyrimidine and purine bases were synthesized with phosphodiester, phosphorothioate, and both linkages (phosphorothioate and phosphodiester) present in the same oligonucleotide as a chimera in high yields. The oligonucleotides were characterized by HPLC, capillary gel electrophoresis, and ESMS. The effect of this modification on the affinity of the oligonucleotides for complementary RNA and on nuclease stability was evaluated. The 2′-O-DMAOE modification enhanced the binding affinity of the oligonucleotides for the complementary RNA (and not for DNA). The modified oligonucleotides that possessed the phosphodiester backbone demonstrated excellent resistance to nuclease with t1/2 > 24 h.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 433288-70-1